Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy

Introduction: Hypertrophies of the cardiac septum are caused either by aortic valve stenosis (AVS) or by congenital hypertrophic obstructive cardiomyopathy (HOCM). As they induce cardiac remodeling, these cardiac pathologies may promote an arrhythmogenic substrate with associated malignant ventricul...

Full description

Bibliographic Details
Main Authors: Vera Paar, Michael Haslinger, Philipp Krombholz-Reindl, Stefan Pittner, Matthias Neuner, Peter Jirak, Tobias Kolbitsch, Bernd Minnich, Falk Schrödl, Alexandra Kaser-Eichberger, Kristen Kopp, Andreas Koller, Clemens Steinwender, Michael Lichtenauer, Fabio C. Monticelli, Rainald Seitelberger, Uta C. Hoppe, Christian Dinges, Lukas J. Motloch
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1264216/full
_version_ 1797488921887637504
author Vera Paar
Michael Haslinger
Philipp Krombholz-Reindl
Stefan Pittner
Matthias Neuner
Peter Jirak
Peter Jirak
Tobias Kolbitsch
Bernd Minnich
Falk Schrödl
Alexandra Kaser-Eichberger
Kristen Kopp
Andreas Koller
Clemens Steinwender
Michael Lichtenauer
Fabio C. Monticelli
Rainald Seitelberger
Uta C. Hoppe
Christian Dinges
Lukas J. Motloch
Lukas J. Motloch
Lukas J. Motloch
author_facet Vera Paar
Michael Haslinger
Philipp Krombholz-Reindl
Stefan Pittner
Matthias Neuner
Peter Jirak
Peter Jirak
Tobias Kolbitsch
Bernd Minnich
Falk Schrödl
Alexandra Kaser-Eichberger
Kristen Kopp
Andreas Koller
Clemens Steinwender
Michael Lichtenauer
Fabio C. Monticelli
Rainald Seitelberger
Uta C. Hoppe
Christian Dinges
Lukas J. Motloch
Lukas J. Motloch
Lukas J. Motloch
author_sort Vera Paar
collection DOAJ
description Introduction: Hypertrophies of the cardiac septum are caused either by aortic valve stenosis (AVS) or by congenital hypertrophic obstructive cardiomyopathy (HOCM). As they induce cardiac remodeling, these cardiac pathologies may promote an arrhythmogenic substrate with associated malignant ventricular arrhythmias and may lead to heart failure. While altered calcium (Ca2+) handling seems to be a key player in the pathogenesis, the role of mitochondrial calcium handling was not investigated in these patients to date.Methods: To investigate this issue, cardiac septal samples were collected from patients undergoing myectomy during cardiac surgery for excessive septal hypertrophy and/or aortic valve replacement, caused by AVS and HOCM. Septal specimens were matched with cardiac tissue obtained from post-mortem controls without cardiac diseases (Ctrl).Results and discussion: Patient characteristics and most of the echocardiographic parameters did not differ between AVS and HOCM. Most notably, the interventricular septum thickness, diastolic (IVSd), was the greatest in HOCM patients. Histological and molecular analyses showed a trend towards higher fibrotic burden in both pathologies, when compared to Ctrl. Most notably, the mitochondrial Ca2+ uniporter (MCU) complex associated proteins were altered in both pathologies of left ventricular hypertrophy (LVH). On the one hand, the expression pattern of the MCU complex subunits MCU and MICU1 were shown to be markedly increased, especially in AVS. On the other hand, PRMT-1, UCP-2, and UCP-3 declined with hypertrophy. These conditions were associated with an increase in the expression patterns of the Ca2+ uptaking ion channel SERCA2a in AVS (p = 0.0013), though not in HOCM, compared to healthy tissue. Our data obtained from human specimen from AVS or HOCM indicates major alterations in the expression of the mitochondrial calcium uniporter complex and associated proteins. Thus, in cardiac septal hypertrophies, besides modifications of cytosolic calcium handling, impaired mitochondrial uptake might be a key player in disease progression.
first_indexed 2024-03-10T00:09:13Z
format Article
id doaj.art-78c32d47ee014a5495a47d06850ea9cb
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-03-10T00:09:13Z
publishDate 2023-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-78c32d47ee014a5495a47d06850ea9cb2023-11-23T16:02:40ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-11-011410.3389/fphar.2023.12642161264216Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathyVera Paar0Michael Haslinger1Philipp Krombholz-Reindl2Stefan Pittner3Matthias Neuner4Peter Jirak5Peter Jirak6Tobias Kolbitsch7Bernd Minnich8Falk Schrödl9Alexandra Kaser-Eichberger10Kristen Kopp11Andreas Koller12Clemens Steinwender13Michael Lichtenauer14Fabio C. Monticelli15Rainald Seitelberger16Uta C. Hoppe17Christian Dinges18Lukas J. Motloch19Lukas J. Motloch20Lukas J. Motloch21Department of Internal Medicine II, Paracelsus Medical University, Salzburg, AustriaDepartment of Internal Medicine II, Paracelsus Medical University, Salzburg, AustriaDepartment of Cardiac Surgery, Paracelsus Medical University, Salzburg, AustriaDepartment of Legal Medicine and Forensic Psychiatry, Paris-Lodron University of Salzburg, Salzburg, AustriaDepartment of Anesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University, Salzburg, AustriaDepartment of Internal Medicine II, Paracelsus Medical University, Salzburg, AustriaDepartment of Internal Medicine, Hospital Gmünd, Lower Austria, AustriaDepartment of Internal Medicine II, Paracelsus Medical University, Salzburg, AustriaDepartment of Environment and Biodiversity, Paris-Lodron University of Salzburg, Salzburg, AustriaCenter for Anatomy and Cell Biology, Institute of Anatomy and Cell Biology Salzburg, Paracelsus Medical University, Salzburg, AustriaCenter for Anatomy and Cell Biology, Institute of Anatomy and Cell Biology Salzburg, Paracelsus Medical University, Salzburg, AustriaDepartment of Internal Medicine II, Paracelsus Medical University, Salzburg, AustriaResearch Program for Experimental Ophthalmology and Glaucoma Research, Department of Ophthalmology and Optometry, Paracelsus Medical University, Salzburg, AustriaDepartment of Cardiology, Kepler University Hospital, Medical Faculty, Johannes Kepler University Linz, Linz, AustriaDepartment of Internal Medicine II, Paracelsus Medical University, Salzburg, AustriaDepartment of Legal Medicine and Forensic Psychiatry, Paris-Lodron University of Salzburg, Salzburg, AustriaDepartment of Cardiac Surgery, Paracelsus Medical University, Salzburg, AustriaDepartment of Internal Medicine II, Paracelsus Medical University, Salzburg, AustriaDepartment of Cardiac Surgery, Paracelsus Medical University, Salzburg, AustriaDepartment of Internal Medicine II, Paracelsus Medical University, Salzburg, AustriaDepartment of Cardiology, Kepler University Hospital, Medical Faculty, Johannes Kepler University Linz, Linz, Austria0Department of Internal Medicine II, Salzkammergut Klinikum, OÖG, Vöcklabruck, AustriaIntroduction: Hypertrophies of the cardiac septum are caused either by aortic valve stenosis (AVS) or by congenital hypertrophic obstructive cardiomyopathy (HOCM). As they induce cardiac remodeling, these cardiac pathologies may promote an arrhythmogenic substrate with associated malignant ventricular arrhythmias and may lead to heart failure. While altered calcium (Ca2+) handling seems to be a key player in the pathogenesis, the role of mitochondrial calcium handling was not investigated in these patients to date.Methods: To investigate this issue, cardiac septal samples were collected from patients undergoing myectomy during cardiac surgery for excessive septal hypertrophy and/or aortic valve replacement, caused by AVS and HOCM. Septal specimens were matched with cardiac tissue obtained from post-mortem controls without cardiac diseases (Ctrl).Results and discussion: Patient characteristics and most of the echocardiographic parameters did not differ between AVS and HOCM. Most notably, the interventricular septum thickness, diastolic (IVSd), was the greatest in HOCM patients. Histological and molecular analyses showed a trend towards higher fibrotic burden in both pathologies, when compared to Ctrl. Most notably, the mitochondrial Ca2+ uniporter (MCU) complex associated proteins were altered in both pathologies of left ventricular hypertrophy (LVH). On the one hand, the expression pattern of the MCU complex subunits MCU and MICU1 were shown to be markedly increased, especially in AVS. On the other hand, PRMT-1, UCP-2, and UCP-3 declined with hypertrophy. These conditions were associated with an increase in the expression patterns of the Ca2+ uptaking ion channel SERCA2a in AVS (p = 0.0013), though not in HOCM, compared to healthy tissue. Our data obtained from human specimen from AVS or HOCM indicates major alterations in the expression of the mitochondrial calcium uniporter complex and associated proteins. Thus, in cardiac septal hypertrophies, besides modifications of cytosolic calcium handling, impaired mitochondrial uptake might be a key player in disease progression.https://www.frontiersin.org/articles/10.3389/fphar.2023.1264216/fullleft ventricular hypertrophyaortic valve stenosishypertrophic obstructive cardiomyopathyfibrosiscalciummitochondria
spellingShingle Vera Paar
Michael Haslinger
Philipp Krombholz-Reindl
Stefan Pittner
Matthias Neuner
Peter Jirak
Peter Jirak
Tobias Kolbitsch
Bernd Minnich
Falk Schrödl
Alexandra Kaser-Eichberger
Kristen Kopp
Andreas Koller
Clemens Steinwender
Michael Lichtenauer
Fabio C. Monticelli
Rainald Seitelberger
Uta C. Hoppe
Christian Dinges
Lukas J. Motloch
Lukas J. Motloch
Lukas J. Motloch
Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy
Frontiers in Pharmacology
left ventricular hypertrophy
aortic valve stenosis
hypertrophic obstructive cardiomyopathy
fibrosis
calcium
mitochondria
title Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy
title_full Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy
title_fullStr Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy
title_full_unstemmed Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy
title_short Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy
title_sort hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy
topic left ventricular hypertrophy
aortic valve stenosis
hypertrophic obstructive cardiomyopathy
fibrosis
calcium
mitochondria
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1264216/full
work_keys_str_mv AT verapaar hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT michaelhaslinger hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT philippkrombholzreindl hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT stefanpittner hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT matthiasneuner hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT peterjirak hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT peterjirak hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT tobiaskolbitsch hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT berndminnich hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT falkschrodl hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT alexandrakasereichberger hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT kristenkopp hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT andreaskoller hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT clemenssteinwender hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT michaellichtenauer hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT fabiocmonticelli hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT rainaldseitelberger hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT utachoppe hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT christiandinges hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT lukasjmotloch hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT lukasjmotloch hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy
AT lukasjmotloch hypertrophiccardiomyopathyischaracterizedbyalterationsofthemitochondrialcalciumuniportercomplexproteinsinsightsfrompatientswithaorticvalvestenosisversushypertrophicobstructivecardiomyopathy